Showing results (11-20 of 22) with videos related to

Sort By:
Pageof 3
Frontiers in Oncology|February 25, 2026
Efficacy and safety of dinutuximab beta combined with GM-CSF and isotretinoin ± chemotherapy as first-line maintenance treatment for pediatric high-risk neuroblastoma in ChinaWen Zhao, Peiyi Yang, Jing Qin, et al.
Pediatric Investigation|August 28, 2020
Analysis of the short-term curative effect of 356 cases of intraocular retinoblastoma in childrenMei Jin, Junyang Zhao, Dawei Zhang, et al.
Pediatric Investigation|November 5, 2020
Acute myeloid leukemia following a primary mediastinal germ cell tumorHuimin Hong, Yan Su, Chenghao Chen, et al.
Cancer Innovation|December 21, 2023
Hepatoblastoma with neonatal necrotizing enterocolitis: Two case reportsSidou He, Xisi Wang, Chao Duan, et al.
Pediatric Hematology and Oncology|November 9, 2021
The expression of PHOX2B in bone marrow and peripheral blood predicts adverse clinical outcome in non-high-risk neuroblastomaHongjun Fan, Tianyu Xing, Huimin Hong, et al.
Translational Pediatrics|August 15, 2024
Clinical outcomes and prognostic factors of parameningeal rhabdomyosarcoma in children and adolescents: results of two consecutive protocolsChao Duan, Sidou He, Xiaoli Ma, et al.
Cancer Innovation|December 21, 2023
Clinical characteristics of malignant germ cell tumors in adolescents: A multicenter 10-year retrospective study in BeijingQian Zhao, Miao Li, Qing Sun, et al.
Cancer Medicine|February 23, 2019
Dynamic alterations of plasma cell free DNA in response to chemotherapy in children with neuroblastomaYan Su, Lijun Wang, Xisi Wang, et al.
Cancer Medicine|June 16, 2018
Plasma cell-free DNA quantification is highly correlated to tumor burden in children with neuroblastomaXisi Wang, Lijun Wang, Yan Su, et al.
Molecular Oncology|September 8, 2020
Implementation of the plasma MYCN/NAGK ratio to detect MYCN amplification in patients with neuroblastomaYan Su, Lijun Wang, Qian Zhao, et al.
Pageof 3